Groupe Nature acquires Winco

Groupe Nature has signed an agreement with Nicolas Watine, founder and CEO of Winco, to acquire his stake in the comany. It specializes in the distribution of health and cosmetic products in parapharmacies affiliated to supermarket chains. This acquisition strengthens Groupe Nature’s position as a multi-channel specialist in the distribution of organic health products.

Founded in 1997, Groupe Nature distributes organic health products, mainly food supplements and cosmetics, through organic specialty shops, pharmacies and online.

Also founded in 1997, Winco is a reference distributor in the French parapharmacy market.

Oaklins’ team in France advised Groupe Nature on the acquisition of Winco.

Service

M&A buy-side

Parties

“We are very proud to integrate Winco into our group and we thank the Oaklins personal care and nutrition team for its commitment and expertise in achieving this transaction, which will allow us to extend our distribution channels to the health food industry and to develop Winco’s health product offering into the organic sector.”

Laurent Ducrocq

CEO, Groupe Nature

Talk to the deal team

Ludovic Beaulieu

Partner

Paris, France
Oaklins France

View profile Get in touch

Related deals

SulAmérica and Rede D’Or São Luiz have announced a combination

Financial Services | Healthcare

SulAmérica and Rede D’Or São Luiz have announced a combination

SulAmérica (B3:SULA11), a leading insurance company in Brazil, has announced a combination with Rede D’Or São Luiz S.A. (B3:RDOR3), the largest Brazilian hospital network. The companies had a combined market value of approximately US$21 billion on 18 February 2022.

Learn more

Dan Deal has been acquired by Shufersal

Consumer & Retail

Dan Deal has been acquired by Shufersal

The owners of Dan Deal have sold the company to Shufersal.

Learn more

Agar Scientific has been acquired by Calibre Scientific

Private Equity | Healthcare

Agar Scientific has been acquired by Calibre Scientific

Agar Scientific Ltd. (Agar) has been sold to Molecular Dimensions Limited, a subsidiary of Calibre Scientific, Inc., a US-based life sciences company, owned by international private investment firm StoneCalibre.

Learn more